Back to the Future: Lessons Learned From the 1918 Influenza Pandemic

Frontiers in Cellular and Infection Microbiology

Volumn 8, Issue , 2018, Pages

  Short, Kirsty R ^a   Kedzierska, Katherine ^b   van de Sandt, Carolien E ^b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SANQUIN RESEARCH   (Netherlands)

Author keywords

1918; external factors; host factors; influenza; pandemic; prevention; societal factors; viral factors

Indexed keywords

AGE; GENETIC PREDISPOSITION; GENETICS; GLOBAL HEALTH; HISTORY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); MIXED INFECTION; MORTALITY; PATHOGENICITY; PATHOLOGY; SPANISH INFLUENZA; VIROLOGY;

AGE FACTORS; COINFECTION; GENETIC PREDISPOSITION TO DISEASE; GLOBAL HEALTH; HISTORY, 20TH CENTURY; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA PANDEMIC, 1918-1919; INFLUENZA, HUMAN;

EID: 85055162433     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2018.00343     Document Type: Review

References (267)

1. Afkhami A., (2003). Compromised constitutions: the Iranian experience with the 1918 influenza pandemic. Bull. Hist. Med. 77, 367–392. 10.1353/bhm.2003.004912955964
2. Ahmed R., Oldstone M. B., Palese P., (2007). Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat. Immunol. 8, 1188–1193. 10.1038/ni153017952044
3. Alexander J. B., (1919). Cases resembling encephalitis lethargica occurring during the influenza epidemic. Br. Med. J. 1, 794–795. 10.1136/bmj.1.3052.79420769532
4. Ashley E. A., Pyae Phyo A., Woodrow C. J., (2018). Malaria. Lancet 391, 1608–1621. 10.1016/S0140-6736(18)30324-629631781
5. Audubon (2018). Audubon's Birds and Climate Change Report. Available online at: http://climate.audubon.org (Accessed May 6, 2018).
6. Bajardi P., Poletto C., Ramasco J. J., Tizzoni M., Colizza V., Vespignani A., (2011). Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic. PLoS ONE 6:e16591. 10.1371/journal.pone.001659121304943
7. Ballinger M. N., Standiford T. J., (2010). Postinfluenza bacterial pneumonia: host defenses gone awry. J. Interferon Cytokine Res. 30, 643–652. 10.1089/jir.2010.004920726789
8. Barber D. L., Andrade B. B., Sereti I., Sher A., (2012). Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat. Rev. Microbiol. 10, 150–156. 10.1038/nrmicro271222230950
9. Barry J. M., (2004). The site of origin of the 1918 influenza pandemic and its public health implications. J. Transl. Med. 2:3. 10.1186/1479-5876-2-314733617
10. Barry J. M., Viboud C., Simonsen L., (2008). Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J. Infect. Dis. 198, 1427–1434. 10.1086/59245418808337
11. Beck M. A., Handy J., Levander O. A., (2004). Host nutritional status: the neglected virulence factor. Trends Microbiol. 12, 417–423. 10.1016/j.tim.2004.07.00715337163
12. Belser J. A., Gustin K. M., Pearce M. B., Maines T. R., Zeng H., Pappas C., et al. (2013). Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556–559. 10.1038/nature1239123842497
13. Beveridge W. I., (1977). The start of pandemics: site, season and spread. Dev. Biol. Stand. 39, 443–444. 342316
14. Blakely D. E., (2006). Mass Mediated Disease: A Case Study Analysis of Three Flu Pandemics and Public Health Policy. Oxford: Lexington Books.
15. Bodewes R., de Mutsert G., van der Klis F. R., Ventresca M., Wilks S., Smith D. J., et al. (2011a). Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin. Vaccine Immunol. 18, 469–476. 10.1128/CVI.00396-1021209157
16. + T cell immunity in children. J. Virol. 85, 11995–12000. 10.1128/JVI.05213-1121880755
17. Bodewes R., Kreijtz J. H., Baas C., Geelhoed-Mieras M. M., de Mutsert G., van Amerongen G., (2009a). Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS ONE 4:e5538. 10.1371/journal.pone.000553819440239
18. Bodewes R., Kreijtz J. H., Geelhoed-Mieras M. M., van Amerongen G., Verburgh R. J., van Trierum S. E., et al. (2011c). Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J. Virol. 85, 2695–2702. 10.1128/JVI.02371-1021228239
19. Bodewes R., Kreijtz J. H., Rimmelzwaan G. F., (2009b). Yearly influenza vaccinations: a double-edged sword? Lancet Infect. Dis. 9, 784–788. 10.1016/S1473-3099(09)70263-419879807
20. Bootsma M. C., Ferguson N. M., (2007). The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc. Natl. Acad. Sci U.S.A. 104, 7588–7593. 10.1073/pnas.061107110417416677
21. Brightman I. J., (1935). Streptococcus infection occurring in ferrets inoculated with human influenza virus. Yale J. Biol. Med. 8, 127–135. 21433668
22. Brundage J. F., (2006). Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis. 6, 303–312. 10.1016/S1473-3099(06)70466-216631551
23. Brundage J. F., Shanks G. D., (2008). Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg. Infect. Dis. 14, 1193–1199. 10.3201/eid1408.07131318680641
24. Butler D., (2010). Portrait of a year-old pandemic. Nature 464, 1112–1113. 10.1038/4641112a20414281
25. CDC (2009). Interim Recommendations for Facemask and Respirator Use to Reduce 2009 Influenza A (H1N1) Virus Transmission. Available online at: https://www.cdc.gov/h1n1flu/masks.htm (Accessed May 10, 2018).
26. Chan D. K., Yang S. X., Mullan B., Du X., Zhang X., Chatzisarantis N. L., et al. (2015). Preventing the spread of H1N1 influenza infection during a pandemic: autonomy-supportive advice versus controlling instruction. J. Behav. Med. 38, 416–426. 10.1007/s10865-014-9616-z25542273
27. Chen W., Lim C. E., Kang H. J., Liu J., (2011). Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials. PLoS ONE 6:e28093. 10.1371/journal.pone.002809322164232
28. Chen Y., Liang W., Yang S., Wu N., Gao H., Sheng J., et al. (2013). Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916–1925. 10.1016/S0140-6736(13)60903-423623390
29. Cheng K. F., Leung P. C., (2007). What happened in China during the 1918 influenza pandemic? Int. J. Infect. Dis. 11, 360–364. 10.1016/j.ijid.2006.07.00917379558
30. Chertow D. S., Memoli M. J., (2013). Bacterial coinfection in influenza: a grand rounds review. J. Am. Med. Assoc. 309, 275–282. 10.1001/jama.2012.19413923321766
31. Chien Y. W., Klugman K. P., Morens D. M., (2009). Bacterial pathogens and death during the 1918 influenza pandemic. N. Engl. J. Med. 361, 2582–2583. 10.1056/NEJMc090821620032332
32. Chowell G., Echevarría-Zuno S., Viboud C., Simonsen L., Tamerius J., Miller M. A., et al. (2011). Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med. 8:e1000436. 10.1371/journal.pmed.100043621629683
33. Ciancanelli M. J., Huang S. X., Luthra P., Garner H., Itan Y., Volpi S., et al. (2015). Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448–453. 10.1126/science.aaa157825814066
34. Clemens E. B., van de Sandt C., Wong S. S., Wakim L. M., Valkenburg S. A., (2018). Harnessing the power of T cells, the promising hope for a Universal Influenza vaccine. Vaccines 6:E18. 10.3390/vaccines602001829587436
35. Cliff A. D., Haggett P., Graham R., (1983). Reconstruction of diffusion at local scales: the 1846, 1882 and 1904 measles epidemics in northwest Iceland. J. Hist. Geogr. 9, 347–368. 10.1016/0305-7488(83)90254-211635231
36. Cohen M. L., (2000). Changing patterns of infectious disease. Nature 406, 762–767. 10.1038/3502120610963605
37. Collins S. D., (1931). Age and sex incidence of influenza and pneumonia morbidity and mortality in the epidemic of 1928-29 with comparative data for the epidemic of 1918-19: based on surveys of families in certain localities in the united states following the epidemics. Public Health Rep. 46, 1909–1937. 10.2307/458013919315308
38. Conenello G. M., Zamarin D., Perrone L. A., Tumpey T., Palese P., (2007). A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3, 1414–1421. 10.1371/journal.ppat.003014117922571
39. Cooper N. J., Sutton A. J., Abrams K. R., Wailoo A., Turner D., Nicholson K. G., (2003). Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326:1235. 10.1136/bmj.326.7401.123512791735
40. Cowling B. J., Zhou Y., Ip D. K., Leung G. M., Aiello A. E., (2010). Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol. Infect. 138, 449–456. 10.1017/S095026880999165820092668
41. Crosby A. W., (1976). Epidemic and Peace 1918. Santa Barbara, CA: Abc-Clio.
42. Crosby A. W., (2003). America's Forgotten Pandemic: the Influenza of 1918. Cambridge: Cambridge University Press.
43. Dawood F. S., Iuliano A. D., Reed C., Meltzer M. I., Shay D. K, Cheng P. Y., et al. (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687–695. 10.1016/S1473-3099(12)70121-422738893
44. De Clercq E., (2006). Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov. 5, 1015–1025. 10.1038/nrd217517139286
45. De Jong J. C., Rimmelzwaan G. F., Fouchier R. A., Osterhaus A. D., (2000). Influenza virus: a master of metamorphosis. J. Infect. 40, 218–228. 10.1053/jinf.2000.065210908015
46. de Jong M. D., Simmons C. P., Thanh T. T., Hien V. M., Smith G. J., Chau T. N., et al. (2006). Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203–1207. 10.1038/nm147716964257
47. de Vries R. D., McQuaid S., van Amerongen G., Yüksel S., Verburgh R. J., Osterhaus A. D., et al. (2012). Measles immune suppression: lessons from the macaque model. PLoS Pathog. 8:e1002885. 10.1371/journal.ppat.100288522952446
48. de Wit E., Siegers J. Y., Cronin J. M., Weatherman S., van den Brand J. M., Leijten L. M., et al. (2018). 1918 H1N1 influenza virus replicates and induces proinflammatory cytokine responses in extrarespiratory tissues of ferrets. J. Infect. Dis. 217, 1237–1246. 10.1093/infdis/jiy00329329410
49. Diavatopoulos D. A., Short K. R., Price J. T., Wilksch J. J., Brown L. E., Briles D. E., et al. (2010). Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24, 1789–1798. 10.1096/fj.09-14677920097876
50. Dowdle W. R., (1999). Influenza A virus recycling revisited. Bull. World Health Organ. 77, 820–828. 10593030
51. Duncan C. J., Duncan S. R., Scott S., (1997). The dynamics of measles epidemics. Theor. Popul. Biol. 52, 155–163. 10.1006/tpbi.1997.13269356330
52. Dunham E. J., Dugan V. G., Kaser E. K., Perkins S. E., Brown I. H., Holmes E. C., et al. (2009). Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J. Virol. 83, 5485–5494. 10.1128/JVI.02565-0819297491
53. + monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection. EMBO Rep. 16, 1203–1218. 10.15252/embr.20154047326265006
54. Ellis J. S., Zambon M. C., (2002). Molecular diagnosis of influenza. Rev. Med. Virol. 12, 375–389. 10.1002/rmv.37012410529
55. Epstein S. L., (2006). Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193, 49–53. 10.1086/49898016323131
56. Everitt A. R., Clare S., Pertel T., John S. P., Wash R. S., Smith S. E., et al. (2012). IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523. 10.1038/nature1092122446628
57. Flint S. M., Davis J. S., Su J. Y., Oliver-Landry E. P., Rogers B. A., Goldstein A., et al. (2010). Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory. Med. J. Aust. 192, 617–622. 20477746
58. Francis T., de Torregrosa M. V., (1945). Combined infection of mice with influenzae, H. and influenza virus by the intranasal route. J. Infect. Dis. 76, 70–77.
59. Fraser C., Cummings D. A., Klinkenberg D., Burke D. S., Ferguson N. M., (2011). Influenza transmission in households during the 1918 pandemic. Am. J. Epidemiol. 174, 505–514. 10.1093/aje/kwr12221749971
60. Frost W. H., (1919). Public health weekly reports for August 15, 1919. Public Health Rep. 34, 1823–1926. 10.2307/457527119314682
61. Garten R. J., Davis C. T., Russell C. A., Shu B., Lindstrom S., Balish A., et al. (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197–201. 10.1126/science.117622519465683
62. Georgantopoulos P., Bergquist E. P., Knaup R. C., Anthony J. R., Bailey T. C., Williams M. P., et al. (2009). Importance of routine public health influenza surveillance: detection of an unusual W-shaped influenza morbidity curve. Am. J. Epidemiol. 170, 1533–1540. 10.1093/aje/kwp30519903724
63. Gibbon J., (1919). Acquired immunity in influenza. Lancet 193:583. 10.1016/S0140-6736(01)25706-7
64. Glaser L., Stevens J., Zamarin D., Wilson I. A., García-Sastre A., Tumpey T. M., et al. (2005). A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 79:11533–11536. 10.1128/JVI.79.17.11533-11536.200516103207
65. Glover R. E., (1941). Spread of infection from the respiratory tract of the ferret. II. Association of influenza A virus and streptococcus type C. Br. J. Exp. Pathol. 22, 98–107.
66. Goronzy J. J., Weyand C. M., (2013). Understanding immunosenescence to improve responses to vaccines. Nat. Immunol. 14, 428–436. 10.1038/ni.258823598398
67. Gras S., Kedzierski L., Valkenburg S. A., Laurie K., Liu Y. C., Denholm J. T., et al. (2010). Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sci. U.S.A. 107, 12599–12604. 10.1073/pnas.100727010720616031
68. Griffin D. E., (2010). Measles virus-induced suppression of immune responses. Immunol. Rev. 236, 176–189. 10.1111/j.1600-065X.2010.00925.x20636817
69. Gunaratnam P. J., Tobin S., Seale H., Marich A., McAnulty J., (2014). Airport arrivals screening during pandemic (H1N1) 2009 influenza in New South Wales, Australia. Med. J. Aust. 200, 290–292. 10.5694/mja13.1083224641156
70. Hammond J. A. B., Rolland W., Shore T. H. G., (1917). Purulent bronchiti. Lancet 190, 41–46. 10.1016/S0140-6736(01)56229-7
71. Hancock K., Veguilla V., Lu X., Zhong W., Butler E. N., Sun H., et al. (2009). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945–1952. 10.1056/NEJMoa090645319745214
72. Harford C. G., Smith M. R., Wood W. B., (1946). Sulfonamide chemotherapy of combined infection with influenza virus and bacteria. J. Exp. Med. 83, 505–518. 10.1084/jem.83.6.505
73. Hartmann B. M., Albrecht R. A., Zaslavsky E., Nudelman G., Pincas H., Marjanovic N., et al. (2017). Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nat. Commun. 8:1931. 10.1038/s41467-017-02035-929203926
74. Hatchett R. J., Mecher C. E., Lipsitch M., (2007). Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc. Natl. Acad. Sci. U.S.A. 104, 7582–7587. 10.1073/pnas.061094110417416679
75. Hay A. J., Hayden F. G., (2013). Oseltamivir resistance during treatment of H7N9 infection. Lancet 381, 2230–2232. 10.1016/S0140-6736(13)61209-X23809549
76. Hay A. J., McCauley J. W., (2018). The WHO global influenza Surveillance and Response System (GISRS) - a future perspective. Influenza Other Respir Viruses. 12, 551–557 10.1111/irv.12565
77. Hayden F. G., Belshe R., Villanueva C., Lanno R., Hughes C., Small I., et al. (2004). Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J. Infect. Dis. 189, 440–449. 10.1086/381128
78. Hayward A. C., Wang L., Goonetilleke N., Fragaszy E. B., Bermingham A., Copas A., et al. (2015). Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study. Am. J. Respir. Crit. Care Med. 191, 1422–1431. 10.1164/rccm.201411-1988OC25844934
79. Herfst S., Schrauwen E. J., Linster M., Chutinimitkul S., de Wit E., Munster V. J., et al. (2012). Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534–1541. 10.1126/science.121336222723413
80. Hernandez N., Melki I., Jing H., Habib T., Huang S. S. Y., Danielson J., et al. (2018). Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. J Exp Med. 10.1084/jem.20180628. [Epub ahead of print]30143481
81. Hildreth M. L., (1991). The influenza epidemic of 1918-1919 in France: contemporary concepts of aetiology, therapy, and prevention. Soc. Hist. Med. 4, 277–294. 10.1093/shm/4.2.27711622956
82. Hirsch H. H., Kaufmann G., Sendi P., Battegay M., (2004). Immune reconstitution in HIV-infected patients. Clin. Infect. Dis. 38, 1159–1166. 10.1086/38303415095223
83. Hoffman B. L., (2011). Influenza activity in Saint Joseph, Missouri 1910-1923: evidence for an early wave of the 1918 pandemic. PLoS Curr. 2:RRN1287. 10.1371/currents.RRN128722183018
84. Hollingsworth T. D., Ferguson N. M., Anderson R. M., (2006). Will travel restrictions control the international spread of pandemic influenza? Nat. Med. 12, 497–499. 10.1038/nm0506-49716675989
85. Horimoto T., Kawaoka Y., (1994). Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J. Virol. 68, 3120–3128. 8151777
86. Hrincius E. R., Liedmann S., Finkelstein D., Vogel P., Gansebom S., Ehrhardt C., et al. (2015). Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic? J. Infect. Dis. 211, 1418–1428. 10.1093/infdis/jiu60925367299
87. Hufnagel L., Brockmann D., Geisel T., (2004). Forecast and control of epidemics in a globalized world. Proc. Natl. Acad. Sci. U.S.A. 101, 15124–15129. 10.1073/pnas.030834410115477600
88. Hulme K. D., Gallo L. A., Short K. R., (2017). Influenza virus and glycemic variability in diabetes: a killer combination? Front. Microbiol. 8:861. 10.3389/fmicb.2017.0086128588558
89. Ikonen N., Strengell M., Kinnunen L., Osterlund P., Pirhonen J., Broman M., et al. (2010). High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15:19478. 10.2807/ese.15.05.19478-en20144443
90. Imai M., Watanabe T., Hatta M., Das S. C., Ozawa M., Shinya K., et al. (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486, 420–428. 10.1038/nature1083122722205
91. Jagger B. W., Memoli M. J., Sheng Z. M., Qi L., Hrabal R. J., Allen G. L., et al. (2010). The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. MBio 1:e00067–10. 10.1128/mBio.00067-1020689744
92. Jain S., Kamimoto L., Bramley A. M., Schmitz A. M., Benoit S. R., Louie J., et al. (2009). Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 361, 1935–1944. 10.1056/NEJMoa090669519815859
93. Johnson N., (2006). Britain and the 1918-19 Influenza Pandemic: A Dark Epilogue. Abingdon: Taylor & Francis Ltd.
94. Johnson N. P., Mueller J., (2002). Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull. Hist. Med. 76, 105–115. 10.1353/bhm.2002.002211875246
95. Joseph C., Togawa Y., Shindo N., (2013). Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses 7(Suppl. 2), 105–113. 10.1111/irv.1208924034494
96. Kash J. C., Tumpey T. M., Proll S. C., Carter V., Perwitasari O., Thomas M. J., et al. (2006). Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443, 578–581. 10.1038/nature0518117006449
97. Kash J. C., Walters K. A., Davis A. S., Sandouk A., Schwartzman L. M., Jagger B.W., et al. (2011). Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio 2:e00172–11. 10.1128/mBio.00172-1121933918
98. Kawaoka Y., Krauss S., Webster R. G., (1989). Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63, 4603–4608. 2795713
99. Kawaoka Y., Webster R. G., (1988). Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85, 324–328. 10.1073/pnas.85.2.3242829180
100. Keeling A. W., (2010). Alert to the necessities of the emergency: U.S. nursing during the 1918 influenza pandemic. Publ. Health Rep. 125(Suppl. 3), 105–12. 10.1177/00333549101250S31320568572
101. Khan K., Arino J., Hu W., Raposo P., Sears J., Calderon F., et al. (2009). Spread of a novel influenza A (H1N1) virus via global airline transportation. N. Engl. J. Med. 361, 212–214. 10.1056/NEJMc090455919564630
102. Klaassen M., Hoye B. J., Nolet B. A., Buttemer W. A., (2012). Ecophysiology of avian migration in the face of current global hazards. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 367, 1719–1732. 10.1098/rstb.2012.000822566678
103. Kobasa D., Jones S. M., Shinya K., Kash J. C., Copps J., Ebihara H., et al. (2007). Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319–323. 10.1038/nature0549517230189
104. Kobasa D., Takada A., Shinya K., Hatta M., Halfmann P., Theriault S., et al. (2004). Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431, 703–707. 10.1038/nature0295115470432
105. Kobayashi M., Davis S. M., Utsunomiya T., Pollard R. B., Suzuki F., (1999). Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. Am. J. Chin. Med. 27, 53–62. 10.1142/S0192415X9900008210354817
106. Krammer F., Smith G. J. D., Fouchier R. A. M., Peiris M., Kedzierska K., Doherty P. C., et al. (2018). Influenza. Nat. Rev. Dis Prim. 4:3. 10.1038/s41572-018-0002-y
107. Kreijtz J. H., de Mutsert G., van Baalen C. A., Fouchier R. A., Osterhaus A. D., Rimmelzwaan G. F., (2008). Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 82, 5161–5166. 10.1128/JVI.02694-0718353950
108. Kunisaki K. M., Janoff E. N., (2009). Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect. Dis. 9, 493–504. 10.1016/S1473-3099(09)70175-619628174
109. La Ruche G., Tarantola A., Barboza P., Vaillant L., Gueguen J., Gastellu-Etchegorry M., et al. (2009). The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill. 14:19366 10.2807/ese.14.42.19366-en19883543
110. Langford C. M., Storey P., (1992). Influenza in Sri Lanka, 1918–1919: the impact of a new disease in a premodern third world setting. Health Transition Rev. 2, 97–123.
111. Larson E. L., Cohen B., Baxter K. A., (2012). Analysis of alcohol-based hand sanitizer delivery systems: efficacy of foam, gel, and wipes against influenza A (H1N1) virus on hands. Am. J. Infect. Control 40, 806–809. 10.1016/j.ajic.2011.10.01622325728
112. Lee B., Robinson K. M., McHugh K. J., Scheller E. V., Mandalapu S., Chen C., et al. (2015). Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 309, L158–L167. 10.1152/ajplung.00338.201426001778
113. Lee L. Y., Ha do L. A., Simmons C., de Jong M. D., Chau N. V., Schumacher R., et al. (2008). Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118, 3478–3490. 10.1172/JCI3246018802496
114. Lemey P., Rambaut A., Bedford T., Faria N., Bielejec F., Baele G., et al. (2014). Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2. PLoS Pathog. 10:e1003932. 10.1371/journal.ppat.100393224586153
115. Little P., Stuart B., Hobbs F. D., Moore M., Barnett J., Popoola D., et al. (2015). An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial. Lancet 386, 1631–1639. 10.1016/S0140-6736(15)60127-126256072
116. Liu Y., Li S., Zhang G., Nie G., Meng Z., Mao D., et al. (2013). Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus. (2014). BMC Immunol. 14:37. 10.1186/1471-2172-14-37
117. Louie J. K., Acosta M., Samuel M. C., Schechter R., Vugia D. J., Harriman K., et al. (2011). California Pandemic Working, A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin. Infect. Dis. 52, 301–312. 10.1093/cid/ciq152
118. Louria D. B., Blumenfeld H. L., Ellis J. T., Kilbourne E. D., Rogers D. E., (1959). Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. J. Clin. Invest. 38(1 Part 2), 213–265. 10.1172/JCI10379113620784
119. Luk J., Gross P., Thompson W. W., (2001). Observations on mortality during the 1918 influenza pandemic. Clin. Infect. Dis. 33, 1375–1378. 10.1086/32266211565078
120. MacDougall H., (2007). Toronto's health department in action: influenza in 1918 and SARS in 2003. J. Hist. Med. Allied Sci. 62, 56–89 10.1093/jhmas/jrl04217035296
121. Madhav N., (2013). Modeling a modern-day spanish flu pandemic, in Aircurrents, ed Markey M. J.. Available online at: www.air-worldwide.com/Publications/AIR-Currents/2013/Attachments/Modeling-a-Modern-Day-Spanish-Flu-Pandemic (Accessed May 10, 2018).
122. Madhi S. A., Klugman K. P., Vaccine Trialist G., (2004). A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat. Med. 10, 811–813. 10.1038/nm107715247911
123. Mamelund S. E., Haneberg B., Mjaaland S., (2016). A missed summer wave of the 1918-1919 influenza pandemic, evidence from household surveys in the United States and Norway. Open Forum Infect. Dis. 3:ofw040. 10.1093/ofid/ofw04027006964
124. Mathews J. D., McBryde E. S., McVernon J., Pallaghy P. K., McCaw J. M., (2010). Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. BMC Infect. Dis. 10:128. 10.1186/1471-2334-10-12820497585
125. Mazel-Sanchez B., Boal Carvalho I., Silva F., Dijkman R., Schmolke M., (2018). H5N1 influenza A virus PB1-F2 relieves HAX-1-mediated restriction of avian virus polymerase PA in human lung cells. J. Virol. 92. e00425–18 10.1128/JVI.00425-1829563290
126. McAuley J. L., Hornung F., Boyd K. L., Smith A. M., McKeon R., Bennink J., et al. (2007). Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2, 240–249. 10.1016/j.chom.2007.09.00118005742
127. McCullers J. A., (2006). Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571–582. 10.1128/CMR.00058-0516847087
128. McCullers J. A., Bartmess K. C., (2003). Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 187, 1000–1009. 10.1086/36816312660947
129. McMichael A. J., Gotch F. M., Noble G. R., Beare P., (1983). Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309, 13–17. 10.1056/NEJM1983070730901036602294
130. Mehle A., Doudna J. A., (2009). Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl. Acad. Sci. U.S.A. 106, 21312–21316. 10.1073/pnas.091191510619995968
131. Mehle A., Dugan V. G., Taubenberger J. K., Doudna J. A., (2012). Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. J. Virol. 86, 1750–1757. 10.1128/JVI.06203-1122090127
132. Memoli M. J., Morens D. M., Taubenberger J. K., (2008). Pandemic and seasonal influenza: therapeutic challenges. Drug Discov. Today 13, 590–595. 10.1016/j.drudis.2008.03.02418598914
133. Memoli M. J., Tumpey T. M., Jagger B. W., Dugan V. G., Sheng Z. M., Qi L., et al. (2009). An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 393, 338–345. 10.1016/j.virol.2009.08.02119733889
134. Millard J., Ugarte-Gil C., Moore D. A., (2015). Multidrug resistant tuberculosis. BMJ 350:h882. 10.1136/bmj.h88225721508
135. Mills I. D., (1986). The 1918-1919 influenza pandemic–the Indian experience. Indian Econ. Soc. Hist. Rev. 23, 1–40. 10.1177/001946468602300102
136. Mina M. J., Metcalf C. J., de Swart R. L., Osterhaus A. D., Grenfell B. T., (2015). Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348, 694–699. 10.1126/science.aaa366225954009
137. Monsalvo A. C., Batalle J. P., Lopez M. F., Krause J. C., Klemenc J., Hernandez J. Z., et al. (2011). Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17, 195–199. 10.1038/nm.226221131958
138. Morales K. F., Paget J., Spreeuwenberg P., (2017). Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 - a global mortality impact modeling study. BMC Infect. Dis. 17:642. 10.1186/s12879-017-2730-028946870
139. Morens D. M., Fauci A. S., (2007). The 1918 influenza pandemic: insights for the 21st century. J. Infect. Dis. 195, 1018–1028. 10.1086/51198917330793
140. Morens D. M., Taubenberger J. K., (2015). A forgotten epidemic that changed medicine: measles in the US Army, 1917-18. Lancet Infect. Dis. 15, 852–861. 10.1016/S1473-3099(15)00109-726070967
141. Morens D. M., Taubenberger J. K., Fauci A. S., (2008). Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962–970. 10.1086/59170818710327
142. Morens D. M., Taubenberger J. K., Fauci A. S., (2009). The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 361, 225–229. 10.1056/NEJMp090481919564629
143. Morgan O. W., Bramley A., Fowlkes A., Freedman D. S., Taylor T. H., Gargiullo P., et al. (2010). Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 5:e9694. 10.1371/journal.pone.000969420300571
144. Moss W. J., Griffin D. E., (2012). Measles. Lancet 379, 153–164. 10.1016/S0140-6736(10)62352-521855993
145. Moss W. J., Ota M. O., Griffin D. E., (2004). Measles: immune suppression and immune responses. Int. J. Biochem. Cell Biol. 36, 1380–1385. 10.1016/j.biocel.2004.01.01915147716
146. Mossad S. B., (2009). Influenza in long-term care facilities: preventable, detectable, treatable. Cleve. Clin. J. Med. 76, 513–521. 10.3949/ccjm.76a.0902219726556
147. Murray C. J., Lopez A. D., Chin B., Feehan D., Hill K., (2006). Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 368, 2211–2218. 10.1016/S0140-6736(06)69895-417189032
148. Murray M. A., Chotirmall S. H., (2015). The Impact of Immunosenescence on pulmonary disease. Mediators Inflamm. 2015:692546. 10.1155/2015/692546
149. Nakamura S., Davis K. M., Weiser J. N., (2011). Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657–3665. 10.1172/JCI5776221841308
150. National Center for Respiratory Diseases CDC, and Centers for Disease and Prevention (CDC). (2009). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 58, 1–8.
151. Navarini A. A., Recher M., Lang K. S., Georgiev P., Meury S., Bergthaler A., et al. (2006). Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. U.S.A. 103, 15535–15539. 10.1073/pnas.060732510317030789
152. Noymer A., (2011). The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: an age, period, cohort analysis. Vaccine 29(Suppl. 2), B38–B41. 10.1016/j.vaccine.2011.02.05321757102
153. Noymer A., Garenne M., (2000). The 1918 influenza epidemic's effects on sex differentials in mortality in the United States. Popul. Dev. Rev. 26, 565–581. 10.1111/j.1728-4457.2000.00565.x19530360
154. Oei W., Nishiura H., (2012). The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918–19. Comput. Math. Methods Med. 2012:124861. 10.1155/2012/12486122848231
155. Oi E., (2018). Avian Influenza Portal, Update On Avian Influenza In Animals (types H5 and H7). World Organization for Animal Health. Available online at: http://www.oie.int/animal-health-in-the-world/update-on-avian-influenza/2018/ (Accessed May 12, 2018).
156. Olson D. R., Simonsen L., Edelson P. J., Morse S. S., (2005). Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc. Natl. Acad. Sci. U.S.A. 102, 11059–11063. 10.1073/pnas.040829010216046546
157. Oseasohn R., Adelson L., Kaji M., (1959). Clinicopathologic study of thirty-three fatal cases of Asian influenza. N. Engl. J. Med. 260, 509–518. 10.1056/NEJM19590312260110113632920
158. Oswald N. C., Shooter R. A., Curwen M. P., (1958). Pneumonia complicating Asian influenza. Br. Med. J. 2, 1305–1311. 10.1136/bmj.2.5108.130513596593
159. Oxford J. S., Lambkin R., Sefton A., Daniels R., Elliot A., Brown R., et al. (2005). A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in northern France during the Great War provided the conditions for the emergence of the “Spanish” influenza pandemic of 1918-1919. Vaccine 23, 940–945. 10.1016/j.vaccine.2004.06.03515603896
160. Oxford J. S., Sefton A., Jackson R., Innes W., Daniels R. S., Johnson N. P., (2002). World War I may have allowed the emergence of “Spanish” influenza. Lancet Infect. Dis. 2, 111–114. 10.1016/S1473-3099(02)00185-811901642
161. Oxford J. S., Sefton A., Jackson R., Johnson N. P, Daniels R. S., (1999). Who's that lady? Nat. Med. 5, 1351–1352. 10581070
162. Pada S., Tambyah P. A., (2011). Overview/reflections on the 2009 H1N1 pandemic. Microbes Infect. 13, 470–478. 10.1016/j.micinf.2011.01.00921276873
163. Palmer E., Rice G. W., (1992). A Japanese physician's response to pandemic influenza, Ijiro Gomibuchi and the “Spanish flu” in Yaita-Cho, 1918-1919. Bull. Hist. Med. 66, 560–577. 1472863
164. Pappas C., Aguilar P. V., Basler C. F., Solórzano A., Zeng H., Perrone L. A., et al. (2008). Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 105, 3064–3069. 10.1073/pnas.071181510518287069
165. Patterson K. D., Pyle G. F., (1991). The geography and mortality of the 1918 influenza pandemic. Bull. Hist. Med. 65, 4–21. 2021692
166. Peltola V. T., Murti K. G., McCullers J. A., (2005). Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis. 192, 249–257. 10.1086/43095415962219
167. Perry R. T., Gacic-Dobo M., Dabbagh A., Mulders M. N., Strebel P. M., Okwo-Bele J. M., et al. (2014). Centers for disease and prevention, global control and regional elimination of measles, 2000-2012. MMWR Morb. Mortal. Wkly. Rep. 63, 103–107.
168. Phimister I. R., (1973). The “Spanish” influenza pandemic of 1918 and its impact on the Southern Rhodesian mining industry. Cent. Afr. J. Med. 19, 143–148. 4580865
169. + T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc Natl Acad Sci U.S.A. 111, 1049–1054 10.1073/pnas.132222911124395804
170. Ravenholt R. T., Foege W. H., (1982). 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2, 860–864. 10.1016/S0140-6736(82)90820-06126720
171. Redford P. S., Mayer-Barber K. D., McNab F. W., Stavropoulos E., Wack A., Sher A., et al. (2014). Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J. Infect. Dis. 209, 270–274. 10.1093/infdis/jit42423935205
172. Reed C., Katz J. M., (2010). Serological surveys for 2009 pandemic influenza A H1N1. Lancet 375, 1062–1063. 10.1016/S0140-6736(09)62194-220096449
173. Reid A. H., Fanning T. G., Hultin J. V., Taubenberger J. K., (1999). Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. U.S.A. 96, 1651–1656. 10.1073/pnas.96.4.16519990079
174. Reid A. H., Fanning T. G., Janczewski T. A., Lourens R. M., Taubenberger J. K., (2004a). Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J. Virol. 78, 12462–12470. 10.1128/JVI.78.22.12462-12470.200415507633
175. Reid A. H., Janczewski T. A., Lourens R. M., Elliot A. J., Daniels R. S., Berry C. L., et al. (2003). 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerging Infect. Dis. 9, 1249–1253. 10.3201/eid0910.02078914609459
176. Reid A. H., Taubenberger J. K., Fanning T. G., (2004b). Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat. Rev. Microbiol. 2, 909–914. 10.1038/nrmicro102715494747
177. Reyes L., Arvelo W., Estevez A., Gray J., Moir J. C., Gordillo B., et al. (2010). Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009. Influenza Other Respir. Viruses 4, 129–140. 10.1111/j.1750-2659.2010.00138.x20409209
178. Rice G. W., (2011). Japan and New Zealand in the 1918 influenza pandemic: comparative perspectives on official responses and crisis management, in Spanish Influenza Pandemic of 1918–1919: New Perspectives, ed Killingray D., (Melbourne, VIC: Routledge).
179. Rice G. W., Palmer E., (1993). Pandemic influenza in Japan, 1918–19, mortality patterns and official responses. J. Japan. Stud. 19, 389–420. 10.2307/132645
180. Richard M., Schrauwen E. J., de Graaf M., Bestebroer T. M., Spronken M. I., van Boheemen S., et al. (2013). Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501, 560–563. 10.1038/nature1247623925116
181. RIVM (2018). De Lci-Richtlijnen, Stappenplannen En Draaiboeken Zijn Er Voor En Door Professionals in De Infectieziektebestrijding, Influenza. RIVM. Available online at: https://lci.rivm.nl/richtlijnen/influenza (Accessed May 05, 2018).
182. Robertson L., Caley J. P., Moore J., (1958). Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 2, 233–236. 10.1016/S0140-6736(58)90060-613564806
183. Robinson K. R., (1990). The role of nursing in the influenza epidemic of 1918–1919. Nurs. Forum 25, 19–26. 10.1111/j.1744-6198.1990.tb00845.x2235652
184. Rockman S., Brown L., (2010). Pre-pandemic and pandemic influenza vaccines. Hum. Vaccin. 6, 792–801. 10.4161/hv.6.10.1291520935469
185. Rudenko L., Sellwood C., Russell C., Herfst S., Gross D., Dingwall R., (2015). Will there ever be a new influenza pandemic and are we prepared? Vaccine 33, 7037–7040. 10.1016/j.vaccine.2015.08.04526413881
186. Rvachev L. A., Longini I. M., (1985). A mathematical-model for the global spread of influenza. Math. Biosci. 75, 3–22. 10.1016/0025-5564(85)90064-1
187. Sauerbrei A., Langenhan T., Brandstadt A., Schmidt-Ott R., Krumbholz A., Girschick H., et al. (2014). Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010. Euro Surveill. 19. 24524235
188. Schäfer J. R., Kawaoka Y., Bean W. J., Süss J., Senne D., Webster R. G., (1993). Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194, 781–788. 10.1006/viro.1993.13197684877
189. Scholtissek C., Rohde W., Von Hoyningen V., Rott R., (1978). On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87, 13–20. 10.1016/0042-6822(78)90153-8664248
190. Schotsaert M., García-Sastre A., (2014). Influenza vaccines: a moving interdisciplinary field. Viruses 6, 3809–3826. 10.3390/v610380925302957
191. Schrauwen E. J., Herfst S., Leijten L. M., van Run P., Bestebroer T. M., Linster M., et al. (2012). The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J. Virol. 86, 3975–3984. 10.1128/JVI.06828-1122278228
192. Shaman J., Lipsitch M., (2013). The El Nino-Southern Oscillation (ENSO)-pandemic influenza connection: coincident or causal? Proc. Natl. Acad. Sci. U.S.A. 110(Suppl. 1), 3689–3691. 10.1073/pnas.1107485109
193. Shanks G. D., (2015). Synergistic mortality caused by Plasmodium falciparum during the 1918 influenza pandemic. Am. J. Trop. Med. Hyg. 92, 941–942. 10.4269/ajtmh.14-079225802427
194. Shanks G. D., Brundage J. F., (2012). Pathogenic responses among young adults during the 1918 influenza pandemic. Emerging Infect. Dis. 18, 201–207. 10.3201/eid1802.10204222306191
195. Shanks G. D., Brundage J. F., (2013). Pacific islands which escaped the 1918–1919 influenza pandemic and their subsequent mortality experiences. Epidemiol. Infect. 141, 353–356. 10.1017/S095026881200086622564320
196. Shanks G. D., Burroughs S., Sohn J. D., Waters N. C., Smith V. F., Waller M., et al. (2016b). Variable mortality from the 1918–1919 influenza pandemic during military training. Mil. Med. 181, 878–882. 10.7205/MILMED-D-15-0012427483527
197. Shanks G. D., Burroughs S. A., Sohn J. D., Waters N. C., Smith V. F., Waller M., et al. (2016a). Enhanced risk of illness during the 1918 influenza pandemic after previous influenza-like illnesses in three military populations. Epidemiol. Infect. 144, 2043–2048. 10.1017/S095026881600047926957052
198. Shanks G. D., Hu Z., Waller M., Lee S. E., Terfa D., Howard A., et al. (2014). Measles epidemics of variable lethality in the early 20th century. Am. J. Epidemiol. 179, 413–422. 10.1093/aje/kwt28224284015
199. Shanks G. D., Lee S. E., Howard A., Brundage J. F., (2011a). Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911. Am. J. Epidemiol. 173, 1211–1222. 10.1093/aje/kwq50421498623
200. Shanks G. D., Mackenzie A., McLaughlin R., Waller M., Dennis P., Lee S. E., et al. (2010). Mortality risk factors during the 1918-1919 influenza pandemic in the Australian army. J. Infect. Dis. 201, 1880–1889. 10.1086/65286820450336
201. Shanks G. D., MacKenzie A., Waller M., Brundage J. F., (2011b). Low but highly variable mortality among nurses and physicians during the influenza pandemic of 1918-1919. Influenza Other Respir. Viruses 5, 213–219. 10.1111/j.1750-2659.2010.00195.x21477141
202. Shanks G. D., Wilson N., Kippen R., Brundage J. F., (2018). The unusually diverse mortality patterns in the Pacific region during the 1918–21 influenza pandemic: reflections at the pandemic's centenary. Lancet Infect Dis. 10.1016/S1473-3099(18)30178-629754745 [Epub ahead of print].
203. Sheng Z. M., Chertow D. S., Ambroggio X., McCall S., Przygodzki R. M., Cunningham R. E., et al. (2011). Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc. Natl. Acad. Sci. U.S.A. 108, 16416–16421. 10.1073/pnas.111117910821930918
204. Sheridan P. A., Paich H. A., Handy J., Karlsson E. A., Hudgens M. G., Sammon A. B., et al. (2012). Obesity is associated with impaired immune response to influenza vaccination in humans. Int. J. Obes. 36, 1072–1077. 10.1038/ijo.2011.20822024641
205. Sheth A. N., Patel P., Peters P. J., (2011). Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic. Curr. HIV/AIDS Rep. 8, 181–191. 10.1007/s11904-011-0086-421710214
206. Shope R. E., (1958). Influenza: history, epidemiology, and speculation. Public Health Rep. 73, 165–178. 10.2307/459007213506005
207. Short K. R., Habets M. N., Hermans P. W., Diavatopoulos D. A., (2012a). Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol. 7, 609–624. 10.2217/fmb.12.2922568716
208. Short K. R., Reading P. C., Brown L. E., Pedersen J., Gilbertson B., Job E. R., et al. (2013). Influenza-induced inflammation drives pneumococcal otitis media. Infect. Immun. 81, 645–652. 10.1128/IAI.01278-1223319557
209. Short K. R., Reading P. C., Wang N., Diavatopoulos D. A., Wijburg O. L., (2012b). Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. MBio 3:e00255-12. 10.1128/mBio.00255-1223015738
210. Shulman S. T., Shulman D. L., Sims R. H., (2009). The tragic 1824 journey of the Hawaiian king and queen to London: history of measles in Hawaii. Pediatr. Infect. Dis. J. 28, 728–733. 10.1097/INF.0b013e31819c972019633516
211. Simonsen L., Chowell G., Andreasen V., Gaffey R., Barry J., Olson D., et al. (2018). A review of the 1918 herald pandemic wave: importance for contemporary pandemic response strategies. Ann. Epidemiol. 28, 281–288. 10.1016/j.annepidem.2018.02.01329530388
212. Simonsen L., Clarke M. J., Schonberger L. B., Arden N. H., Cox N. J., Fukuda K., (1998). Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178, 53–60. 10.1086/5156169652423
213. Slepushkin A. N., (1959). The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull. World Health Organ. 20, 297–301. 13651915
214. Smith A. M., Adler F. R., Ribeiro R. M., Gutenkunst R. N., McAuley J. L., McCullers J.A., et al. (2013). Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog. 9:e1003238. 10.1371/journal.ppat.100323823555251
215. Smith G. J., Bahl J., Vijaykrishna D., Zhang J., Poon L. L., Chen H., et al. (2009a). Dating the emergence of pandemic influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 106, 11709–11712. 10.1073/pnas.090499110619597152
216. Smith G. J., Vijaykrishna D., Bahl J., Lycett S. J., Worobey M., Pybus O. G., et al. (2009b). Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459, 1122–1125. 10.1038/nature0818219516283
217. Smith W., Andrewes C. H., Laidlaw P. P., (1933). A virus obtained from influenza patients. Lancet 222, 66–68. 10.1016/S0140-6736(00)78541-2
218. Spinney L., (2017). Pale Rider: The Spanish Flu of 1918 and How It Changed the World. New York, NY: Public Affairs.
219. Sridhar S., Begom S., Bermingham A., Hoschler K., Adamson W., Carman W., et al. (2013). Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305–1312. 10.1038/nm.335024056771
220. Starko K. M., (2009). Salicylates and pandemic influenza mortality, 1918–1919 pharmacology, pathology, and historic evidence. Clin. Infect. Dis. 49, 1405–1410. 10.1086/60606019788357
221. Subbarao E. K., London W., Murphy B. R., (1993). A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67, 1761–1764. 8445709
222. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., et al. (1998). Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393–396. 10.1126/science.279.5349.3939430591
223. Suess T., Remschmidt C., Schink S. B., Schweiger B., Nitsche A., Schroeder K., et al. (2012). The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009–2011. BMC Infect. Dis. 12:26. 10.1186/1471-2334-12-2622280120
224. Suguitan A. L., Jr Matsuoka Y., Lau Y. F., Santos C. P., Vogel L., Cheng L. I., et al. (2012). The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J. Virol. 86, 2706–2714. 10.1128/JVI.05546-1122205751
225. Taubenberger J. K., Baltimore D., Doherty P. C., Markel H., Morens D. M., Webster R. G., et al. (2012). Reconstruction of the 1918 influenza virus: unexpected rewards from the past. MBio 3:e00201–12. 10.1128/mBio.00201-1222967978
226. Taubenberger J. K., Morens D. M., (2006). 1918 Influenza: the mother of all pandemics. Emerging Infect. Dis. 12, 15–22. 10.3201/eid1209.05-097916494711
227. Taubenberger J. K., Reid A. H., Janczewski T. A., Fanning T. G., (2001). Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 1829–1839. 10.1098/rstb.2001.102011779381
228. Taubenberger J. K., Reid A. H., Krafft A. E., Bijwaard K. E., Fanning T. G., (1997). Initial genetic characterization of the 1918 “Spanish” influenza virus. Science 275, 1793–1796. 10.1126/science.275.5307.17939065404
229. Taubenberger J. K., Reid A. H., Lourens R. M., Wang R., Jin G., Fanning T. G., (2005). Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889–893. 10.1038/nature0423016208372
230. Thomas Y., Boquete-Suter P., Koch D., Pittet D., Kaiser L., (2014). Survival of influenza virus on human fingers. Clin. Microbiol. Infect. 20, O58–O64. 10.1111/1469-0691.1232423927722
231. To K. K., Hung I. F., Li I. W., Lee K. L., Koo C. K., Yan W. W., et al. (2010). Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin. Infect. Dis. 50, 850–859. 10.1086/65058120136415
232. To K. K. W., Zhou J., Song Y. Q., Hung I. F. N., Ip W. C. T., Cheng Z. S., et al. (2014). Surfactant protein B gene polymorphism is associated with severe influenza. Chest 145, 1237–1243. 10.1378/chest.13-165124337193
233. Tognotti E., (2003). Scientific triumphalism and learning from facts: bacteriology and the “Spanish flu” challenge of 1918. Soc. Hist. Med. 16, 97–110. 10.1093/shm/16.1.9714598819
234. Tomkins S. M., (1992). The influenza epidemic of 1918–19 in Western Samoa. J. Pac. Hist. 27, 181–197. 10.1080/00223349208572706
235. Tumpey T. M., Basler C. F., Aguilar P. V., Zeng H., Solórzano A., Swayne D. E., et al. (2005). Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77–80. 10.1126/science.111939216210530
236. Tumpey T. M., Maines T. R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., et al. (2007). A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315, 655–659. 10.1126/science.113621217272724
237. Valleron A. J., Cori A., Valtat S., Meurisse S., Carrat F., Boëlle P. Y., (2010). Transmissibility and geographic spread of the 1889 influenza pandemic. Proc. Natl. Acad. Sci. U.S.A. 107, 8778–8781. 10.1073/pnas.100088610720421481
238. + T-cells. J Infect Dis. 218, 581–585. 10.1093/infdis/jiy21829659927
239. + T cell response is long-lived. J. Infect. Dis. 212, 81–5. 10.1093/infdis/jiv01825583167
240. van de Sandt C. E., Kreijtz J. H., de Mutsert G., Geelhoed-Mieras M. M., Hillaire M. L., Vogelzang-van Trierum S. E., et al. (2014). Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J. Virol. 88, 1684–1693. 10.1128/JVI.02843-1324257602
241. + T cells is determined by extraepitopic amino acid residues. J. Virol. 90, 1009–1022. 10.1128/JVI.02439-1526537686
242. + T lymphocytes. J Virol. 92:e00232–18. 10.1128/JVI.00232-1829593036
243. van der Sluijs K. F., Nijhuis M., Levels J. H., Florquin S., Mellor A. L., Jansen H. M., et al. (2006). Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J. Infect. Dis. 193, 214–222. 10.1086/49891116362885
244. van Genugten M. L. L., Heijnen M. L. A., Jager J. C., (2001). Scenario-ontwikkeling zorgvraag bij een influenza pandemie, in RIVM-Rapport. RIVM.
245. Van Kerkhove M. D., Vandemaele K. A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C. A., et al. (2011). Infection, risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 8:e1001053. 10.1371/journal.pmed.100105321750667
246. van Schaik L., Bakker T., (2017). Climate-migration-security: Making the most of a contested relationship, in Clingendael Policy Brief (Den Haag: Planetary Security Initiative).
247. Wahl B., O'Brien K. L., Greenbaum A., Majumder A., Liu L., Chu Y., et al. (2018). Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob. Health 6, e744–e757. 10.1016/S2214-109X(18)30247-X29903376
248. + T cells. (2010). Nat. Commun. 6:6833. 10.1038/ncomms7833
249. Watanabe T., Watanabe S., Shinya K., Kim J. H., Hatta M., Kawaoka Y., (2009). Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc. Natl. Acad. Sci. U.S.A. 106, 588–592. 10.1073/pnas.080695910619114663
250. Watanabe T., Zhong G., Russell C. A., Nakajima N., Hatta M., Hanson A., et al. (2014). Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. Cell Host Microbe 15, 692–705. 10.1016/j.chom.2014.05.00624922572
251. Wilson H. E., Saslaw S., Doan C. A., Woolpert O. C., Schwab J. L., (1947). Reactions of monkeys to experimental mixed influenza and streptococcus infections: an analysis of the relative roles of humoral and cellular immunity, with the description of an intercurrent nephritic syndrome. J. Exp. Med. 85, 199–215. 10.1084/jem.85.2.19919871608
252. Wong V. W., Cowling B. J., Aiello A. E., (2014). Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis. Epidemiol. Infect. 142, 922–932. 10.1017/S095026881400003X24572643
253. World Health Organization (2005). Evolution of H5N1 avian influenza viruses in Asia. Emerging Infect. Dis. 11, 1515–21. 10.3201/eid1110.050644
254. World Health Organization (2018a). Global Influenza Virological Surveillance. Available online at: http://www.who.int/gho/epidemic_diseases/influenza/virological_surveillance/en/ (Accessed May 6, 2018).
255. World Health Organization (2018b). Pandemic Preparedness. Available online at: http://www.who.int/influenza/preparedness/pandemic/en/ (Accessed May 12, 2018).
256. World Health Organization Writing Group Bell D., Nicoll A., Fukuda K., Horby P., Monto A., et al. (2006). Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerging Infect. Dis. 12, 88–94. 10.3201/eid1201.05137116494723
257. Worobey M., Han G. Z., Rambaut A., (2014). Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U.S.A. 111, 8107–8112. 10.1073/pnas.132419711124778238
258. Wu J. T., Cowling B. J., Lau E. H., Ip D. K., Ho L. M., Tsang T., et al. (2010). School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerging Infect. Dis. 16, 538–541. 10.3201/eid1603.09121620202441
259. Yu X., Tsibane T., McGraw P. A., House F. S., Keefer C. J., Hicar M. D., et al. (2008). Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532–536. 10.1038/nature0723118716625
260. Zambon M., (2014). Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy. Curr. Opin. Infect. Dis. 27, 560–565. 10.1097/QCO.000000000000011325333476
261. Zhang Y. H., Zhao Y., Li N., Peng Y. C., Giannoulatou E., Jin R. H., et al. (2013). Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat. Commun. 4:1418. 10.1038/ncomms243323361009
262. Zhou J., To K. K., Dong H., Cheng Z. S., Lau C. C., Poon V. K., et al. (2012). A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection. J. Infect. Dis. 206, 495–503. 10.1093/infdis/jis37822693232
263. Zhu H., Wang D., Kelvin D. J., Li L., Zheng Z., Yoon S. W., et al. (2013). Infectivity, transmission, and pathology of human H7N9 influenza in ferrets and pigs. Science 341:183–186. 10.1126/science.1239844. 23704376
264. Zhu W., Zhou J., Li Z., Yang L., Li X., Huang W., et al. (2017). Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. 22:30533. 10.2807/1560-7917.ES.2017.22.19.3053328537546
265. Ziegler T., Mamahit A., Cox N. J., (2018). 65 Years of influenza surveillance by a WHO-coordinated global network. Influenza Other Respir Viruses (2018). 12 558–565 10.1111/irv.12570
266. Zumla A., Raviglione M., Hafner R., von Reyn C. F., (2013). Tuberculosis. N. Engl. J. Med. 368, 745–755. 10.1056/NEJMra1200894
267. Zúñiga J., Buendía-Roldán I., Zhao Y., Jiménez L., Torres D., Romo J., et al. (2012). Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur. Respir. J. 39, 604–610. 10.1183/09031936.0002061121737555